Beijing Tiantan Biological Stock Price To Book
| 600161 Stock | 19.94 0.17 0.85% |
Beijing Tiantan Biological fundamentals help investors to digest information that contributes to Beijing Tiantan's financial success or failures. It also enables traders to predict the movement of Beijing Stock. The fundamental analysis module provides a way to measure Beijing Tiantan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Beijing Tiantan stock.
Beijing | Price To Book |
Beijing Tiantan Biological Company Price To Book Analysis
Beijing Tiantan's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Beijing Tiantan Price To Book | 3.71 X |
Most of Beijing Tiantan's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beijing Tiantan Biological is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Beijing Tiantan Biological has a Price To Book of 3.7053 times. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The price to book for all China stocks is notably lower than that of the firm.
Beijing Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beijing Tiantan's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beijing Tiantan could also be used in its relative valuation, which is a method of valuing Beijing Tiantan by comparing valuation metrics of similar companies.Beijing Tiantan is currently under evaluation in price to book category among its peers.
Beijing Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0826 | ||||
| Profit Margin | 0.24 % | ||||
| Operating Margin | 0.43 % | ||||
| Current Valuation | 34.66 B | ||||
| Shares Outstanding | 1.98 B | ||||
| Shares Owned By Insiders | 53.55 % | ||||
| Shares Owned By Institutions | 14.46 % | ||||
| Price To Book | 3.71 X | ||||
| Price To Sales | 7.54 X | ||||
| Revenue | 5.18 B | ||||
| Gross Profit | 2.89 B | ||||
| EBITDA | 2.3 B | ||||
| Net Income | 1.11 B | ||||
| Total Debt | 1.43 B | ||||
| Book Value Per Share | 5.38 X | ||||
| Cash Flow From Operations | 2.39 B | ||||
| Earnings Per Share | 0.64 X | ||||
| Target Price | 29.09 | ||||
| Number Of Employees | 4.86 K | ||||
| Beta | 0.44 | ||||
| Market Capitalization | 39.43 B | ||||
| Total Asset | 14.19 B | ||||
| Retained Earnings | 5.12 B | ||||
| Working Capital | 6.29 B | ||||
| Net Asset | 14.19 B | ||||
| Last Dividend Paid | 0.13 |
About Beijing Tiantan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beijing Tiantan Biological's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beijing Tiantan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beijing Tiantan Biological based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Beijing Stock
Beijing Tiantan financial ratios help investors to determine whether Beijing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Beijing with respect to the benefits of owning Beijing Tiantan security.